Maravai LifeSciences Holdings Inc reports results for the quarter ended in March - Earnings Summary

Maravai Lifesciences Holdings

08/05/2023 23:02

* Maravai LifeSciences Holdings Inc  MRVI.OQ  reported
quarterly
adjusted earnings of 3 cents​​ per share for the quarter ended
in March. The mean expectation of twelve analysts for the
quarter was for earnings of 4 cents per share.
    * Revenue fell 67.7% to $79.03 million from a year ago;
analysts
expected $79.72 million. 
    * Maravai LifeSciences Holdings Inc's reported EPS for the
quarter
was breakeven results​.
    * The mean earnings estimate of analysts had fallen by
about 51%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates 
    * Maravai LifeSciences Holdings Inc shares had risen by 3.3%
this
quarter and gained 1.1% so far this year.
    * The company reported a quarterly loss of $67 thousand.
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
8 at 10:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.04           0.03           Missed
 Dec. 31 2022      0.34           0.35           Beat
 Sep. 30 2022      0.33           0.37           Beat
 Jun. 30 2022      0.45           0.54           Beat